Spontaneous and UV radiation-induced multiple metastatic melanomas in Cdk4R24C/R24C/TPras mice

Elke Hacker1, H Konrad Muller, Nicole Irwin

  • 1Queensland Institute of Medical Research, Brisbane, Queensland, Australia.

Cancer Research
|March 17, 2006
PubMed

Insights

Neonatal UV radiation exposure combined with activated Hras and Cdk4 significantly increases melanoma development and aggressiveness in mice. This suggests germline defects in the pRb pathway may enhance UV-induced melanoma risk.

Area of Science:

  • Oncology
  • Dermatology
  • Molecular Biology

Background:

  • Human melanoma is linked to CDKN2A mutations or CDK4 activation.
  • UV radiation (UVR) is a known melanoma risk factor.
  • Previous studies showed UVR increases melanoma in mice with melanocyte-specific Hras activation (TPras).

Purpose of the Study:

  • To investigate the cooperative effect of activated Cdk4 and activated Hras on melanoma susceptibility in mice.
  • To determine if germline defects abrogating the pRb pathway enhance UVR-induced melanoma.

Main Methods:

  • Utilized genetically engineered mouse models with melanocyte-specific Hras activation (TPras) and varying Cdk4 activation levels (Cdk4(R24C/R24C) and Cdk4(R24C/+)).
  • Administered a single neonatal UV radiation (UVR) dose to assess melanoma development and progression.
  • Compared melanoma penetrance, age of onset, tumor characteristics, and metastatic potential across different genotypes.

Main Results:

  • UVR failed to induce melanoma in Cdk4(R24C/R24C) mice but significantly increased melanoma penetrance and decreased onset age in Cdk4(R24C/R24C)/TPras mice compared to TPras alone.
  • Increased melanoma penetrance was dependent on the threshold of Cdk4 activation.
  • Cdk4(R24C/R24C)/TPras mice developed larger, more aggressive melanomas with higher nuclear atypia and readily metastasized to lymph nodes.
  • Melanomas in TPras mice were histopathologically similar but less aggressive and non-metastatic.

Conclusions:

  • Activated Cdk4 cooperates with activated Hras to enhance susceptibility to UVR-induced melanoma in mice.
  • Germline defects abrogating the pRb pathway, such as Cdk4 activation, can enhance UVR-induced melanoma development and progression.
  • Hras activation initiates UVR-induced melanoma, while Cdk4 activation drives tumor progression towards more aggressive, metastatic disease.